[go: up one dir, main page]

CL2014003014A1 - Proceso para la preparacion de un compuesto derivado de undecapeptidos ciclicos que comprende los pasos de: acilar la ciclosporina a, abrir el anillo de la acetil-ciclosporina a formada y cristalizar el anillo abierto para obtener un compuesto de formula 3 o de formula 4; compuesto undecapeptido ciclico de formula 3 y de formula 4. - Google Patents

Proceso para la preparacion de un compuesto derivado de undecapeptidos ciclicos que comprende los pasos de: acilar la ciclosporina a, abrir el anillo de la acetil-ciclosporina a formada y cristalizar el anillo abierto para obtener un compuesto de formula 3 o de formula 4; compuesto undecapeptido ciclico de formula 3 y de formula 4.

Info

Publication number
CL2014003014A1
CL2014003014A1 CL2014003014A CL2014003014A CL2014003014A1 CL 2014003014 A1 CL2014003014 A1 CL 2014003014A1 CL 2014003014 A CL2014003014 A CL 2014003014A CL 2014003014 A CL2014003014 A CL 2014003014A CL 2014003014 A1 CL2014003014 A1 CL 2014003014A1
Authority
CL
Chile
Prior art keywords
formula
compound
cyclosporine
cyclic
ring
Prior art date
Application number
CL2014003014A
Other languages
English (en)
Inventor
Fabrice Gallou
Bernard Riss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014003014(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2014003014A1 publication Critical patent/CL2014003014A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CL2014003014A 2012-05-09 2014-11-07 Proceso para la preparacion de un compuesto derivado de undecapeptidos ciclicos que comprende los pasos de: acilar la ciclosporina a, abrir el anillo de la acetil-ciclosporina a formada y cristalizar el anillo abierto para obtener un compuesto de formula 3 o de formula 4; compuesto undecapeptido ciclico de formula 3 y de formula 4. CL2014003014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261644616P 2012-05-09 2012-05-09

Publications (1)

Publication Number Publication Date
CL2014003014A1 true CL2014003014A1 (es) 2015-03-06

Family

ID=48444372

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003014A CL2014003014A1 (es) 2012-05-09 2014-11-07 Proceso para la preparacion de un compuesto derivado de undecapeptidos ciclicos que comprende los pasos de: acilar la ciclosporina a, abrir el anillo de la acetil-ciclosporina a formada y cristalizar el anillo abierto para obtener un compuesto de formula 3 o de formula 4; compuesto undecapeptido ciclico de formula 3 y de formula 4.

Country Status (24)

Country Link
US (2) US20150087808A1 (es)
EP (1) EP2847211A1 (es)
JP (3) JP2015517481A (es)
KR (1) KR20150006435A (es)
CN (2) CN104284902A (es)
AR (1) AR090964A1 (es)
AU (2) AU2013257989A1 (es)
BR (1) BR112014027648A2 (es)
CA (1) CA2868940A1 (es)
CL (1) CL2014003014A1 (es)
CO (1) CO7141428A2 (es)
EA (1) EA024903B1 (es)
EC (1) ECSP14030537A (es)
HK (1) HK1202555A1 (es)
IL (1) IL235428A0 (es)
IN (1) IN2014DN08483A (es)
MA (1) MA20150231A1 (es)
MX (1) MX2014013613A (es)
PE (1) PE20142433A1 (es)
PH (1) PH12014502499A1 (es)
SG (1) SG11201406303XA (es)
TN (1) TN2014000411A1 (es)
TW (1) TW201350508A (es)
WO (1) WO2013167703A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693820A (zh) * 2014-11-27 2016-06-22 武汉药明康德新药开发有限公司 一种降解环孢菌素a的方法
JP7634933B2 (ja) 2017-05-12 2025-02-25 中外製薬株式会社 環状有機化合物の製造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT401177B (de) * 1993-10-22 1996-07-25 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3-cephem-4-carbonsäure-derivaten
DE69928938T2 (de) * 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
ATE330968T1 (de) * 1999-02-05 2006-07-15 Debiopharm Sa Cyclosporin-derivate und verfahren zu deren herstellung
DE60208180T2 (de) * 2001-04-20 2006-08-17 Debiopharm S.A. Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
DE60231570D1 (de) * 2001-10-19 2009-04-23 Isotechnika Inc Synthese von Cyclosporinanalogen
TW200505946A (en) 2003-04-08 2005-02-16 Hoffmann La Roche Process for preparation of cyclosporin a analog
BRPI0515494A (pt) * 2004-10-01 2008-07-29 Debiopharm Sa uso de [d-meala] 3-[etval] 4-ciclosporina para o tratamento de infecção por hepatite c e composição farmacêutica compreendendo a referida [d-meala] 3-[etval] 4-ciclosporina
KR20070100284A (ko) * 2004-12-17 2007-10-10 이소테크니카 인코포레이티드 시클로스포린 유사체의 대사산물
EP2124992A2 (en) 2007-01-04 2009-12-02 Debiopharm S.A. Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
AU2008304313B2 (en) 2007-09-26 2013-01-10 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies
US7910378B2 (en) * 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
WO2009098533A1 (en) 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
UA102414C2 (ru) 2008-11-06 2013-07-10 Дебио Решерш Фармасьютик С.А. Циклоундекадепсипептидные соединения для лечения инфекций, вызванных вирусом гепатита с
AU2009334790B2 (en) * 2008-12-31 2016-09-08 Scynexis, Inc. Derivatives of cyclosporin A
KR101476626B1 (ko) * 2009-01-30 2014-12-26 이난타 파마슈티칼스, 인코포레이티드 C형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
WO2012021796A2 (en) * 2010-08-12 2012-02-16 S&T Global, Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Also Published As

Publication number Publication date
CN108715606A (zh) 2018-10-30
CN104284902A (zh) 2015-01-14
BR112014027648A2 (pt) 2017-06-27
IN2014DN08483A (es) 2015-05-08
CO7141428A2 (es) 2014-12-12
HK1202555A1 (en) 2015-10-02
US9840534B2 (en) 2017-12-12
PH12014502499A1 (en) 2014-12-22
KR20150006435A (ko) 2015-01-16
IL235428A0 (en) 2014-12-31
MX2014013613A (es) 2015-02-12
SG11201406303XA (en) 2014-11-27
TW201350508A (zh) 2013-12-16
US20160304554A1 (en) 2016-10-20
PE20142433A1 (es) 2015-02-02
WO2013167703A9 (en) 2014-11-20
EA201492036A1 (ru) 2015-02-27
AU2016222370A1 (en) 2016-09-15
JP2015517481A (ja) 2015-06-22
AU2016222370B2 (en) 2017-10-05
AU2013257989A1 (en) 2014-10-23
JP2018035154A (ja) 2018-03-08
MA20150231A1 (fr) 2015-07-31
WO2013167703A1 (en) 2013-11-14
AR090964A1 (es) 2014-12-17
TN2014000411A1 (en) 2015-12-21
US20150087808A1 (en) 2015-03-26
ECSP14030537A (es) 2015-09-30
EA024903B1 (ru) 2016-10-31
CA2868940A1 (en) 2013-11-14
EP2847211A1 (en) 2015-03-18
JP2020033349A (ja) 2020-03-05

Similar Documents

Publication Publication Date Title
BR112015011112A2 (pt) composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença.
PT2925789T (pt) Processos e equipamentos para a produção de nanocelulose, e composições e produtos produzidos a partir destes
LT3347457T (lt) Tinklainės pigmento epitelio ląstelių, kilusių iš kamieninių ląstelių, valymas macs metodu
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
EP2687510A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLORPYRIDINE
EP2565284A4 (en) METHOD OF EXTRACTION OF GALLIUM FROM A FLIGHT POCKET
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
HK1217489A1 (zh) Flap调节剂
CO6960553A2 (es) Fluorometil-5,6-dihidro-4h-[1,3]oxazinas
EP2820281A4 (en) CONTINUOUS LOW PRESSURE TUBE WITHOUT TURBINE EXHAUST HOUSING
WO2015132803A3 (en) Process for the preparation of (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-d-glucitol and its solvate thereof
EP2867230A4 (en) PROCESS FOR PREPARING 3,5-DISUBSTITUTED 1,2,4-OXADIAZOLES
FR2989426B1 (fr) Turbomachine, telle qu'un turboreacteur ou un turbopropulseur d'avion
EP2738153A4 (en) PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE
BR112014029436A2 (pt) método de obtenção de extrato rico em rutina a partir de uma planta; e extrato rico em rutina de uncaria elliptica
WO2012177678A3 (en) Isotopologues of pomalidomide
CO7151490A2 (es) Métodos para mejorar el rendimento de plantas de cultivos resistentes a 2,4-d
FR3003303B1 (fr) Turbomachine, telle qu'un turboreacteur ou un turbopropulseur d'avion
DK2918682T3 (da) Fremgangsmåde til fremstilling af nyttigt stof, hvor højdensitet-dyrket filamentøs svampestamme anvendes
CL2014003014A1 (es) Proceso para la preparacion de un compuesto derivado de undecapeptidos ciclicos que comprende los pasos de: acilar la ciclosporina a, abrir el anillo de la acetil-ciclosporina a formada y cristalizar el anillo abierto para obtener un compuesto de formula 3 o de formula 4; compuesto undecapeptido ciclico de formula 3 y de formula 4.
EP2586763A4 (en) PROCESS FOR PREPARING 1,1-DICHLOR-2,2,3,3,3-PENTA-FLUORO-PROPANE
IT1405996B1 (it) Procedimento per la preparazione di 2,5-diaminotoluolo
EP2851075A4 (en) PREPARATION WITH 6,7-UNSATED 7-CARBAMOYLMORPHINANE DERIVATIVE
WO2015062937A3 (en) Disperse dyes, their preparation and their use
EP2892914A4 (en) TETRAVERZWEIGTE PEPTIDES AND ANALOGUE AS A NEW CLASS OF ANTIMICROBIAL ACTIVE SUBSTANCES AND THEIR PREPARATION